Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
53.40
-2.45 (-4.39%)
At close: Oct 16, 2025, 3:59 PM
53.40
0.00%
After-hours: Oct 16, 2025, 04:35 PM EDT
-4.39% (1D)
| Bid | 52 |
| Market Cap | 3.13B |
| Revenue (ttm) | 130K |
| Net Income (ttm) | -171.57M |
| EPS (ttm) | -4.41 |
| PE Ratio (ttm) | -12.11 |
| Forward PE | -9.57 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 58 |
| Volume | 914,493 |
| Avg. Volume (20D) | 648,314 |
| Open | 56.02 |
| Previous Close | 55.85 |
| Day's Range | 52.92 - 56.84 |
| 52-Week Range | 26.20 - 63.50 |
| Beta | 1.44 |
| Ex-Dividend Date | n/a |
About APGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+12.64%
Apogee Therapeutics shares are trading higher. BTI...
Unlock content with
Pro Subscription
1 week ago
+18.9%
APGE stock has given up its prior loss. Apogee Therapeutics shares were trading lower after the company announced a proposed underwritten public offering.
